Sheren Al-Obaidi

492 citations
8 papers · 268 indexed · h-index 7
Topics
FOXO transcription factor regulation (2 papers)Alkaline Phosphatase Research Studies (2 papers)Genetic Syndromes and Imprinting (1 paper)

In The Last Decade

Sheren Al-Obaidi

8 papers receiving 262 citations

Peers

Sheren Al-Obaidi
Comparison fields: 5 of 54
  • Molecular Biology 190
  • Oncology 89
  • Immunology 49
  • Cancer Research 39
  • Pathology and Forensic Medicine 30
Replace Shinsuke Araki with:
Shinsuke Araki Japan
Claire Vivo United States
Martyna Pakuła Poland
Laia Vilà Spain
Allan D. Burrows Australia
Faying Xu China
Ifra Mushtaq India
Chizu Kameda Japan
Wachiko Nakata Japan
Brijesh Kumar United States
Sheren Al-Obaidi relative to Shinsuke Araki Japan Shinsuke Araki's profile →
Citations per field
00.5×1.5×
Shinsuke Araki · 1×
Citations per year

Countries citing papers authored by Sheren Al-Obaidi

Since Specialization
Citations

This map shows the geographic impact of Sheren Al-Obaidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheren Al-Obaidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheren Al-Obaidi more than expected).

Fields of papers citing papers by Sheren Al-Obaidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheren Al-Obaidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheren Al-Obaidi. The network helps show where Sheren Al-Obaidi may publish in the future.

Co-authorship network of co-authors of Sheren Al-Obaidi

This figure shows the co-authorship network connecting the top 25 collaborators of Sheren Al-Obaidi. A scholar is included among the top collaborators of Sheren Al-Obaidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheren Al-Obaidi. Sheren Al-Obaidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 12
2 12
3 106
4 6
5 48
6 34
7 26
8 24

About Sheren Al-Obaidi

Sheren Al-Obaidi is a scholar working on Hepatology, Cell Biology and Endocrinology, Diabetes and Metabolism, having authored 8 papers that have together received 268 indexed citations. Recurring topics across this work include FOXO transcription factor regulation (2 papers), Alkaline Phosphatase Research Studies (2 papers) and Genetic Syndromes and Imprinting (1 paper). The work is most often cited by research in Oncology (89 citations), Molecular Biology (190 citations) and Cancer Research (39 citations). Sheren Al-Obaidi has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include John M. Mariadason, Amardeep S. Dhillon, Anderly C. Chüeh, Petranel T. Ferrão, Robert N. Jorissen, Helen Rizos, Karen E. Sheppard, Samantha E. Boyle, Gideon Bollag and Teresa Ward. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026